Role of RLIP76 in Doxorubicin Resistance in Lung Cancer (Review)

International Journal of Oncology - Greece
doi 10.3892/ijo_00000279
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Drug Resistance in Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Causative Role of PDLIM2 Epigenetic Repression in Lung Cancer and Therapeutic Resistance

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

The Biological Role of Epithelial-Mesenchymal Transition in Lung Cancer (Review)

Oncology Reports
MedicineCancer ResearchOncology
2016English

DUSP4 Promotes Doxorubicin Resistance in Gastric Cancer Through Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2017English

Doxorubicin Resistance Induces IL6 Activation in the Colon Cancer Cell Line LS180

Oncology Letters
Cancer ResearchOncology
2018English

Doxorubicin Resistance in Breast Cancer Cells Is Mediated by Extracellular Matrix Proteins

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2008English

P092 Apatinib Reverses Paclitaxel Resistance in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy